Delayed hypersensitivity to cefazolin: report on a case involving lymphocyte transformation studies with different cephalosporins.
BACKGROUND
A cell-mediated immunopathogenic mechanism has been demonstrated in only a few cases of cutaneous reactions to systemically administered cephalosporins.


OBJECTIVE
The aim was to investigate the pathogenic mechanism of a maculopapular rash experienced by a subject during cefazolin therapy.


RESULTS
Prick, intradermal, and patch tests were carried out using penicillin determinants, ampicillin, amoxicillin, cefazolin, cephalothin, cefuroxime, ceftazidime, and ceftriaxone. Those tests for penicillin G and its determinants, as well as for ampicillin and amoxicillin, were negative. The patient displayed patch-test and delayed intradermal-test positivity to all the cephalosporins tested. No specific immunoglobulin E antibodies were found for penicillins or cefazolin. The lymphocyte-transformation-test results were negative for all the penicillins tested and showed a positive concentration-effect curve for cefazolin, ceftazidime, and ceftriaxone at concentrations up to 50 microg/mL. At 100 microg/mL the responses decreased with all the cephalosporins tested. Challenges with penicillin G and amoxicillin were well tolerated, but the challenge with cefazolin was positive.


CONCLUSIONS
The data of this case demonstrate delayed hypersensitivity to cefazolin. Patch tests and delayed-reading intradermal tests can be a simple and effective means of diagnosing this type of reaction. Both in vivo and in vitro studies indicate that the responses were directed toward a determinant shared by all cephalosporins, but not by penicillins. The concentration of the cephalosporins used for the in vitro lymphocyte stimulation was critical, because at the concentrations normally used to test other beta-lactams the response decreased. This phenomenon may be attributable to an immunosuppressive, rather than toxic, effect.
Romano
A
A
Department of Internal Medicine and Geriatrics, UCSC, Columbus, Rome, Italy. columbus.allerg@linet.it
Torres
M J
MJ
Di Fonso
M
M
Leyva
L
L
Andriolo
M
M
Pettinato
R
R
Blanca
M
M
D000328:Adult; D002437:Cefazolin / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D008213:Lymphocyte Activation
D002511:Cephalosporins; D002437:Cefazolin